<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02793843</url>
  </required_header>
  <id_info>
    <org_study_id>2432016</org_study_id>
    <nct_id>NCT02793843</nct_id>
  </id_info>
  <brief_title>Ondansetron vs Ondansetron Plus Dexamethasone for Relieving Intrathecal Morphine Side Effects After C-section</brief_title>
  <official_title>A Randomized Study Evaluating Preventive Role of Ondansetron Versus Ondansetron Plus Dexamethasone for Postoperative Side Effects of Intrathecal Morphine Injection in Patients Undergoing Elective C-section</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Makassed General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Makassed General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: Common adverse side effects related to the use of neuraxial opioids in the
      obstetric population include nausea, vomiting, and pruritus. Serotonin (5-HT3) receptor
      antagonists, in particular ondansetron, have been identified as possible antipruritic agents.
      It was reported that dexamethasone plus ondansetron is more effective than ondansetron for
      prevention of postoperative nausea and vomiting but no additional effect on treating
      pruritus.

      Objectives: The purpose of this study is to compare the effect of prophylactic ondansetron
      versus ondansetron plus dexamethasone after cesarean section on pruritus and postoperative
      nausea and vomiting (PONV).

      Methods: A prospective randomized double blind study that will be conducted between June 2016
      and June 2017. Patients will be randomly allocated into two groups. The first group will
      receive 4 mg intravenous (IV) ondansetron while the other group will receive 4 mg IV
      ondansetron plus 8 mg dexamethasone.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective randomized double blind study will be conducted between June 2016 and June
      2017. The sealed envelope technique will be used to randomly allocate females scheduled for
      elective cesarean section into two groups. After obtaining informed consent, all eligible
      patients will receive spinal anesthesia. The first group will receive 4 mg intravenous (IV)
      ondansetron with 2 ml saline while the other group will receive 4 mg IV ondansetron plus 8 mg
      (2 ml) dexamethasone.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Actual">July 30, 2017</completion_date>
  <primary_completion_date type="Actual">June 15, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pruritus assessed through questionnaire</measure>
    <time_frame>24 hours postoperatively</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post operative nausea and vomiting assessed through questionnaire</measure>
    <time_frame>24 hours postoperatively</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">194</enrollment>
  <condition>Pruritus</condition>
  <condition>Cesarean Section</condition>
  <arm_group>
    <arm_group_label>Ondansetron</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Ondansetron+ dexamethasone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ondansetron (Zofran)</intervention_name>
    <description>Intravenous administration of 4 mg ondansetron 15 minutes before spinal anesthesia</description>
    <arm_group_label>Ondansetron</arm_group_label>
    <arm_group_label>Ondansetron+ dexamethasone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone (Decadron)</intervention_name>
    <description>Intravenous administration of 8 mg dexamethasone 15 minutes before spinal anesthesia</description>
    <arm_group_label>Ondansetron+ dexamethasone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Spinal anesthesia</intervention_name>
    <description>Intrathecal anesthesia by 10 mg hyperbaric marcain, 5 mcg sufentanyl and 150 mcg morphine using 27 G spinal needle (27 G Quincke needle)</description>
    <arm_group_label>Ondansetron</arm_group_label>
    <arm_group_label>Ondansetron+ dexamethasone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiology physical status 1 and 2

          -  Scheduled for elective c-section surgery under spinal anesthesia

        Exclusion Criteria:

          -  Patients with cardiac and psychological problems

          -  Patients who take sedatives or narcotics

          -  Patient who have allergy to study drugs
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Makassed General Hospital</name>
      <address>
        <city>Beirut</city>
        <country>Lebanon</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Lebanon</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 3, 2016</study_first_submitted>
  <study_first_submitted_qc>June 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 8, 2016</study_first_posted>
  <last_update_submitted>November 2, 2017</last_update_submitted>
  <last_update_submitted_qc>November 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Makassed General Hospital</investigator_affiliation>
    <investigator_full_name>Zoher Naja</investigator_full_name>
    <investigator_title>Chairperson of Anesthesia and Pain Management Department</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pruritus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Ondansetron</mesh_term>
    <mesh_term>Morphine</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

